REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 29 filers reported holding REDHILL BIOPHARMA LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $21,000 | -77.4% | 3,200 | -84.4% | 0.00% | -80.0% |
Q1 2020 | $93,000 | -40.4% | 20,500 | +12.3% | 0.01% | +25.0% |
Q2 2018 | $156,000 | +57.6% | 18,250 | -8.8% | 0.00% | +33.3% |
Q1 2018 | $99,000 | -2.9% | 20,000 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $102,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 1,892,593 | $15,292,000 | 6.10% |
GAGNON SECURITIES LLC | 281,080 | $2,271,000 | 0.36% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,029,195 | $16,396,000 | 0.32% |
Annandale Capital, LLC | 43,532 | $352,000 | 0.29% |
WOODWARD DIVERSIFIED CAPITAL, LLC | 23,000 | $186,000 | 0.12% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 20,328 | $164,000 | 0.10% |
Claret Asset Management Corp | 54,972 | $444,000 | 0.09% |
Migdal Insurance & Financial Holdings Ltd. | 890,339 | $7,194,000 | 0.08% |
Shay Capital LLC | 47,800 | $386,000 | 0.08% |
ARS Investment Partners, LLC | 77,714 | $628,000 | 0.08% |